RhumbLine Advisers’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Sell |
113,487
-6,542
| -5% | -$17K | ﹤0.01% | 2997 |
|
|
2025
Q1 | $228K | Sell |
120,029
-9,087
| -7% | -$17.3K | ﹤0.01% | 3043 |
|
|
2024
Q4 | $187K | Buy |
129,116
+3,822
| +3% | +$5.54K | ﹤0.01% | 3229 |
|
|
2024
Q3 | $231K | Sell |
125,294
-6,495
| -5% | -$12K | ﹤0.01% | 3164 |
|
|
2024
Q2 | $132K | Buy |
131,789
+12,315
| +10% | +$12.3K | ﹤0.01% | 3425 |
|
|
2024
Q1 | $237K | Buy |
119,474
+2,942
| +3% | +$5.83K | ﹤0.01% | 3096 |
|
|
2023
Q4 | $182K | Sell |
116,532
-587
| -0.5% | -$916 | ﹤0.01% | 3229 |
|
|
2023
Q3 | $231K | Buy |
117,119
+4,791
| +4% | +$9.44K | ﹤0.01% | 3078 |
|
|
2023
Q2 | $357K | Buy |
+112,328
| New | +$357K | ﹤0.01% | 2896 |
|